U.S. Markets open in 2 hrs 47 mins

Teva announces launch of generic Lunesta tablets in U.S.

Teva Pharmaceutical announces the launch of the generic equivalent to Lunesta , 1, 2 and 3 mg, in the United States. Lunesta Tablets, marketed by Sunovion Pharmaceuticals, had annual sales of approximately $852M in the United States, according to IMS data as of December 2013.